SCHEMBL23584797

SCHEMBL23584797

CN1CCC2(CCCN2CC2OC(n3cnc4c(N)ncnc43)CC2O)C1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 7/20 0.56
▸ WDR77 Q9BQA1 7/20 0.56
▸ POLB P06746 1/20 0.48
▸ ENPP1 P22413 2/20 0.47
▸ P2RY1 P47900 1/20 0.47
▸ HIF1A Q16665 1/20 0.46
▸ TP53 P04637 2/20 0.43
▸ PNP P00491 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ PDE4D Q08499 1/20 0.43
▸ PDE3A Q14432 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ CYP2C9 P11712 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19344019 0.85 PRMT5 (0.77) PRMT5WDR77SMN1; SMN2MAPK1MEN1
SCHEMBL19344532 0.81 PRMT5 (0.77) PRMT5WDR77SMN1; SMN2MAPK1MEN1
SCHEMBL19344073 0.80 PRMT5 (0.81) PRMT5WDR77SMN1; SMN2MAPK1MEN1
SCHEMBL19344531 0.80 PRMT5 (0.79) PRMT5WDR77SMN1; SMN2MAPK1MEN1
SCHEMBL23584811 0.79 PRMT5 (0.50) PRMT5WDR77TP53CYP2C9NFKB1
SCHEMBL23584796 0.79 PRMT5 (0.52) PRMT5WDR77TP53SMN1; SMN2CYP2C9
SCHEMBL19344077 0.79 PRMT5 (0.54) PRMT5WDR77TP53CYP2C9NFKB1
SCHEMBL19344060 0.78 PRMT5 (0.75) PRMT5WDR77SMN1; SMN2MAPK1MEN1
SCHEMBL12837026 0.76 POLB (0.62) POLBENPP1P2RY1HIF1ATP53
SCHEMBL14639883 0.76 POLB (0.62) POLBENPP1P2RY1HIF1ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426664-B1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-06-30 — — EP disclosed
Send feedback